Effectiveness of Oral Nirmatrelvir/Ritonavir vs. Intravenous Three-Day Remdesivir in Preventing Progression to Severe COVID-19: A Single-Center, Prospective, Comparative, Real-Life Study.

Dimitrios BasoulisAristeidis TsakanikasAikaterini GkoufaAikaterini BitsaniGeorgios KaramanakosElpida MastrogianniVasiliki Epameinondas GeorgakopoulouSotiria MakrodimitriPantazis-Michail VoutsinasPanagiota LamprouAthanasios KontosStathis TsiakasMaria N GamaletsouSmaragdi MarinakiNikolaos V Sipsas

Published in: Viruses (2023)

In our patient population of high-risk, mainly immunocompromised, vaccinated patients during the prevalence of the Omicron variant, NMV/r and 3RDV were equally effective early treatments for the prevention of hospitalization and/or death.

Keyphrases

end stage renal disease
ejection fraction
coronavirus disease
randomized controlled trial
sars cov
newly diagnosed
systematic review
chronic kidney disease
peritoneal dialysis
prognostic factors
case report
early onset
patient reported outcomes
antiretroviral therapy
respiratory failure